Functional comparison of Plasmodium falciparum transmission-blocking vaccine candidates by the standard membrane-feeding assay.
about
The cell biology of malaria infection of mosquito: advances and opportunitiesTargeting Human Transmission Biology for Malaria EliminationUtilizing direct skin feeding assays for development of vaccines that interrupt malaria transmission: A systematic review of methods and case study.Immunogenicity studies of proteins forming the T4 phage head surface.RNA Seq analysis of the Eimeria tenella gametocyte transcriptome reveals clues about the molecular basis for sexual reproduction and oocyst biogenesisAlga-produced malaria transmission-blocking vaccine candidate Pfs25 formulated with a human use-compatible potent adjuvant induces high-affinity antibodies that block Plasmodium falciparum infection of mosquitoes.Malaria eradication and elimination: views on how to translate a vision into realityOral Application of T4 Phage Induces Weak Antibody Production in the Gut and in the Blood.An inter-laboratory comparison of standard membrane-feeding assays for evaluation of malaria transmission-blocking vaccines.Antibodies to a single, conserved epitope in Anopheles APN1 inhibit universal transmission of Plasmodium falciparum and Plasmodium vivax malaria.The Ancient Gamete Fusogen HAP2 Is a Eukaryotic Class II Fusion ProteinWheat germ systems for cell-free protein expression.Naturally acquired immunity to sexual stage P. falciparum parasites.The fibrinogen-like domain of FREP1 protein is a broad-spectrum malaria transmission-blocking vaccine antigen.Transmission-blocking activity is determined by transmission-reducing activity and number of control oocysts in Plasmodium falciparum standard membrane-feeding assay.Determinants of Malaria Transmission at the Population Level.Biology of Malaria Transmission.Evaluation of two lead malaria transmission blocking vaccine candidate antibodies in natural parasite-vector combinations.Immune Responses in Malaria.Evaluation of a Plasmodium-specific carrier protein to enhance production of recombinant Pfs25, a leading transmission-blocking vaccine candidate.Molecular definition of multiple sites of antibody inhibition of malaria transmission-blocking vaccine antigen Pfs25.Targeting the Conserved Fusion Loop of HAP2 Inhibits the Transmission of Plasmodium berghei and falciparum.Hap2, a novel gene in Babesia bigemina is expressed in tick stages, and specific antibodies block zygote formation.A male gametocyte osmiophilic body and microgamete surface protein of the rodent malaria parasite Plasmodium yoelii (PyMiGS) plays a critical role in male osmiophilic body formation and exflagellation.Assessment of Antibodies Induced by Multivalent Transmission-Blocking Malaria Vaccines.Unravelling the immune signature of Plasmodium falciparum transmission-reducing immunity.Interaction of Bacteriophages with the Immune System: Induction of Bacteriophage-Specific Antibodies.Acceptability of a herd immunity-focused, transmission-blocking malaria vaccine in malaria-endemic communities in the Peruvian Amazon: an exploratory study.Safety and immunogenicity of a plant-produced Pfs25 virus-like particle as a transmission blocking vaccine against malaria: A Phase 1 dose-escalation study in healthy adultsAn inexpensive open source 3D-printed membrane feeder for human malaria transmission studies
P2860
Q27024179-84F2498B-BE71-4A39-A1E7-340F106F5FD0Q28082362-49A7D06A-991A-4776-8913-0FDCD087F7F4Q30243982-27FD8918-E196-42E2-B646-A538E7068BE0Q34593930-FD5B1EEC-42E2-4E6F-A379-747205AB5F51Q35133018-A29352EC-42A6-4A66-B052-C686C4EF38F8Q35439931-5B41866A-44AA-49C9-9A56-6F00B631EF2AQ35712522-F091A52F-338C-464C-8526-8282E51C3A03Q36076282-1225AF94-6434-4A9B-A8EB-E99C430A109DQ37243605-F1583D20-4190-4004-9A3B-D8BBC59C7ED9Q37546481-64F9D145-53D6-49CC-90F2-FC284B18780FQ37675742-DF7791AB-01E1-47CF-93CD-94996FE337F0Q38220438-CA0D9EF7-BE80-48DA-B221-D28565BAF1C8Q38689928-530CC8F0-6EDA-4430-9242-92BB62FC5745Q38769941-6BA10036-F347-4BA5-AF6B-8C8D5CD1BF27Q38845963-CE35EDA6-3FCA-4D12-9664-2B4DDA3EC17EQ38917744-34584931-7D80-44A1-864C-A4A72638A03FQ39005901-1D0C99AD-6D2A-4A2B-A02F-5D69036DA413Q40103373-D390BB7F-3C0B-4B3B-B516-6A03E0BFF16EQ40259888-66C2728A-B49F-4DF8-AEB0-16D6F6109C2CQ41989340-F151F852-E079-4D40-9669-04BBA5E67DF9Q44169982-F45B0015-B7E3-4805-97EA-E3D413703097Q46246718-746051CB-BB99-45F1-99F2-27F59AFC5BCAQ46262566-3FC5388B-E1C5-426A-A7BF-3D46EB4CFD5BQ47217736-586CEAA0-D4E0-47FE-9D2C-993CB717570AQ49730085-161948B4-A270-4275-B0B9-D7812B174827Q49732059-E666E6FA-F771-483C-8714-E0D11F1CCAC1Q50100593-5C9EA6F8-41F3-4CE6-B42D-9BFE2F037F4FQ55104120-A107ABF2-DE82-474D-87D2-CB843FD0E694Q56342219-21AB8B32-5E64-4328-853E-60E470C71106Q56347967-74BDE303-1009-4B9B-BFBC-D20B35F78ABA
P2860
Functional comparison of Plasmodium falciparum transmission-blocking vaccine candidates by the standard membrane-feeding assay.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 16 September 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Functional comparison of Plasm ...... andard membrane-feeding assay.
@en
Functional comparison of Plasm ...... andard membrane-feeding assay.
@nl
type
label
Functional comparison of Plasm ...... andard membrane-feeding assay.
@en
Functional comparison of Plasm ...... andard membrane-feeding assay.
@nl
prefLabel
Functional comparison of Plasm ...... andard membrane-feeding assay.
@en
Functional comparison of Plasm ...... andard membrane-feeding assay.
@nl
P2093
P2860
P50
P356
P1476
Functional comparison of Plasm ...... andard membrane-feeding assay.
@en
P2093
Ababacar Diouf
Bingbing Deng
Daria Nikolaeva
Eizo Takashima
Gregory Tullo
Samuel E Moretz
P2860
P304
P356
10.1128/IAI.01056-13
P407
P577
2013-09-16T00:00:00Z